Metabolic & Weight Management

Lipo-B12 / MIC Injection

Also known as Lipotropic injection · MIC · Methionine-Inositol-Choline · B12 fat-burner · Lipo-MINO · Lipo-B

PreliminaryIntramuscular injectionSubcutaneous injectionNot FDA-approved as a drug; there is no single approved MIC/Lipo-B12 product, and these formulations have not been evaluated by the FDA for safety or efficacy. Products are prepared by compounding pharmacies under section 503A (patient-specific prescriptions) or by FDA-registered 503B outsourcing facilities, so concentration and quality vary by source; formulations require a prescription. Individual ingredients (methionine, choline, inositol, vitamin B12) are generally recognized as naturally occurring nutrients. For athletes, vitamin B12 (cyanocobalamin) is not prohibited by WADA, and methionine, inositol, and choline are not specifically listed on the WADA Prohibited List; however, athletes should verify any specific compounded product and consult the current WADA/USADA list, since supplement contamination remains a recognized anti-doping risk.

Lipo-B12 / MIC is a compounded injectable that combines the lipotropic agents methionine, inositol, and choline (MIC) with vitamin B12 (commonly cyanocobalamin or methylcobalamin); some formulations omit inositol or add other B-vitamins. The individual components participate in fat and lipid metabolism: choline supports fat transport out of the liver, methionine acts as a methyl donor and sulfur source, inositol is involved in cellular and insulin signaling, and B12 supports red-blood-cell formation, nerve function, and energy metabolism. It is most often marketed as an adjunct to diet and exercise for weight management and energy. The state of evidence is limited: while the ingredients have established metabolic roles, there is little high-quality clinical trial data showing the combination produces meaningful weight loss in people who are not deficient, and major medical reviewers and insurers generally classify lipotropic injections as unproven for weight loss. It is not an FDA-approved drug; products are prepared by compounding pharmacies.

Studied / used for

Investigated as an adjunct to diet and exercise for weight management
Studied for its component roles in hepatic fat metabolism and lipid transport
Investigated for energy and fatigue support, particularly where B12 status is low
Studied for the individual roles of choline, methionine, and inositol in liver function and metabolism

Commonly reported side effects

Injection-site reactions commonly reported, including soreness, redness, or bruising
Mild gastrointestinal symptoms such as nausea or diarrhea reported
Transient dizziness or headache reported
Body or urine odor occasionally reported, attributed to methionine
Flushing reported in some users

Preliminary. Mostly early or animal studies. This reflects the strength of the research base, not effectiveness or a recommendation.

Not medical advice.

This is an educational reference. Peptalk does not recommend, prescribe, endorse, or rate any compound, and provides no dosing information. Do not start, stop, or change any peptide, hormone, supplement, or therapy based on this page. All clinical decisions must be made with your licensed healthcare provider.

← Back to all compounds